USRC Kidney Research
Welcome,         Profile    Billing    Logout  
 1 Trial 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Block, Geoff
FRONTIER, NCT05085275: Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

Completed
3
289
US
Ferric Citrate 1 GM Oral Tablet [AURYXIA], Auryxia, Placebo
USRC Kidney Research, Akebia Therapeutics
Anemia, Iron Deficiency, Hyperphosphatemia, Renal Insufficiency, Chronic, Renal Anemia, Disease Progression, Cardiovascular, Iron
01/24
01/24
NCT05225298: SARS-COV-2 Screening in Dialysis Facilities

Completed
N/A
2389
US
Offering SARS-CoV-2 test
Stanford University, National Institute on Minority Health and Health Disparities (NIMHD), National Institute of Allergy and Infectious Diseases (NIAID)
End-stage Renal Disease, SARS-CoV-2 Acute Respiratory Disease, Dialysis; Complications
08/23
10/23
HOME, NCT04526301: Home With TablO outcoMEs () Registry

Recruiting
N/A
500
US
Tablo Hemodialysis System
Outset Medical
End Stage Renal Disease
07/24
07/24
Brillhart, Stephanie
ROQ-IT, NCT05951192: A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease

Completed
4
161
US
Daprodustat, JESDUVROQ
USRC Kidney Research, GlaxoSmithKline
Anemia, Renal Insufficiency, Chronic, Renal Anemia
02/24
02/24
FRONTIER, NCT05085275: Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

Completed
3
289
US
Ferric Citrate 1 GM Oral Tablet [AURYXIA], Auryxia, Placebo
USRC Kidney Research, Akebia Therapeutics
Anemia, Iron Deficiency, Hyperphosphatemia, Renal Insufficiency, Chronic, Renal Anemia, Disease Progression, Cardiovascular, Iron
01/24
01/24
VOICE, NCT06520826: Vafseo Outcomes In-Center Experience

Recruiting
3
2200
US
Vadadustat, Vafseo, Erythropoiesis Stimulating Agent, Epoetin alfa (EPOGEN), Methoxy polyethylene glycol-epoetin beta (Mircera), or Darbepoetin alfa (Aranesp)
USRC Kidney Research, Akebia Therapeutics
Anemia of Chronic Kidney Disease
06/26
06/26
HOME, NCT04526301: Home With TablO outcoMEs () Registry

Recruiting
N/A
500
US
Tablo Hemodialysis System
Outset Medical
End Stage Renal Disease
07/24
07/24
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Block, Geoff
FRONTIER, NCT05085275: Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

Completed
3
289
US
Ferric Citrate 1 GM Oral Tablet [AURYXIA], Auryxia, Placebo
USRC Kidney Research, Akebia Therapeutics
Anemia, Iron Deficiency, Hyperphosphatemia, Renal Insufficiency, Chronic, Renal Anemia, Disease Progression, Cardiovascular, Iron
01/24
01/24
NCT05225298: SARS-COV-2 Screening in Dialysis Facilities

Completed
N/A
2389
US
Offering SARS-CoV-2 test
Stanford University, National Institute on Minority Health and Health Disparities (NIMHD), National Institute of Allergy and Infectious Diseases (NIAID)
End-stage Renal Disease, SARS-CoV-2 Acute Respiratory Disease, Dialysis; Complications
08/23
10/23
HOME, NCT04526301: Home With TablO outcoMEs () Registry

Recruiting
N/A
500
US
Tablo Hemodialysis System
Outset Medical
End Stage Renal Disease
07/24
07/24
Brillhart, Stephanie
ROQ-IT, NCT05951192: A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease

Completed
4
161
US
Daprodustat, JESDUVROQ
USRC Kidney Research, GlaxoSmithKline
Anemia, Renal Insufficiency, Chronic, Renal Anemia
02/24
02/24
FRONTIER, NCT05085275: Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

Completed
3
289
US
Ferric Citrate 1 GM Oral Tablet [AURYXIA], Auryxia, Placebo
USRC Kidney Research, Akebia Therapeutics
Anemia, Iron Deficiency, Hyperphosphatemia, Renal Insufficiency, Chronic, Renal Anemia, Disease Progression, Cardiovascular, Iron
01/24
01/24
VOICE, NCT06520826: Vafseo Outcomes In-Center Experience

Recruiting
3
2200
US
Vadadustat, Vafseo, Erythropoiesis Stimulating Agent, Epoetin alfa (EPOGEN), Methoxy polyethylene glycol-epoetin beta (Mircera), or Darbepoetin alfa (Aranesp)
USRC Kidney Research, Akebia Therapeutics
Anemia of Chronic Kidney Disease
06/26
06/26
HOME, NCT04526301: Home With TablO outcoMEs () Registry

Recruiting
N/A
500
US
Tablo Hemodialysis System
Outset Medical
End Stage Renal Disease
07/24
07/24

Download Options